about
Intraoperative cell salvage in revision hip surgery.Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative periodAutologous blood in obstetrics: where are we going now?Transfusion management of trauma patientsContamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective Caesarean section.Are cell salvage and autologous blood transfusion safe in endonasal surgery?From bloodless surgery to patient blood management.Should intraoperative cell-salvaged blood be used in patients with suspected or known malignancy?Bleeding management for pediatric craniotomies and craniofacial surgery.Autologous blood salvage in the era of patient blood management.Blood management after total joint arthroplasty in the United States: 19-year trend analysis.Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation.Intraoperative blood salvage and leukocyte depletion during liver transplantation with bacterial contamination.Patient blood management: use of topical hemostatic and sealant agents.Removal of hemangiosarcoma cells from canine blood with a cell salvage system and leukocyte reduction filter.Cost-effectiveness Analysis of Intraoperative Cell Salvage for Obstetric Hemorrhage.Transfusion of intra-operative autologous whole blood: influence on complement activation and interleukin formation.Autologous blood transfusion following red blood cell salvage for the management of blood loss in 3 dogs with hemoperitoneum.
P2860
Q34718581-98E7DB56-5AA0-4B72-A55F-A1B4DDBA3576Q34988663-075540B1-2B91-45EA-A847-50A863F36134Q35874035-1D5EFBD6-8284-4C57-A598-984863771F33Q36684422-B6347E95-F2F2-4AAB-A2EA-7ED7DD1D5375Q36748868-6A450CA3-C8A5-412A-966A-B842CBEC17C4Q37696731-D887BAAF-CE16-4317-9756-2768B1B8EB91Q37975177-FE06CC55-D3CA-4B58-965E-96638471BE1AQ38045253-4D376E81-B2DA-4EB6-813F-32D938FDE146Q38210761-F9944062-7A9F-4B33-9C0B-DF925A1B363FQ38674835-B503097B-906E-4237-B9CA-4F663957FDBAQ39980877-E09CADC3-AA33-4770-A28B-0DCB60C471D2Q41938260-1A933DA2-D9E2-4D05-84B8-B80319E2D855Q43994602-77D6DF0D-EC2D-48B4-B1F8-DDD2B27924B2Q46375927-334F4785-2AF6-40C8-897F-0F602371A046Q48105996-E3732DFF-F6DB-4A72-94E5-84755841B24CQ48585019-64313CE8-B7C8-4920-9430-989EB148D38DQ50122924-BC274273-27A0-42EB-AAB1-8AEF255204C4Q50508978-627DC52C-1F99-4525-9DD3-82F8219ADB0F
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Indications and contraindications of cell salvage.
@ast
Indications and contraindications of cell salvage.
@en
Indications and contraindications of cell salvage.
@nl
type
label
Indications and contraindications of cell salvage.
@ast
Indications and contraindications of cell salvage.
@en
Indications and contraindications of cell salvage.
@nl
prefLabel
Indications and contraindications of cell salvage.
@ast
Indications and contraindications of cell salvage.
@en
Indications and contraindications of cell salvage.
@nl
P1433
P1476
Indications and contraindications of cell salvage.
@en
P2093
Jonathan H Waters
P304
P356
10.1111/J.0041-1132.2004.04176.X
P433
P577
2004-12-01T00:00:00Z